Both in Pharmaceuticals
Nuvation Bio vs Nurix Therapeutics
Over the past year NUVB returned −2.1% and NRIX returned +30.1%; their daily moves had a correlation of 0.26.
NUVB −2.1% NRIX +30.1%Growth of $1, one year, split-adjusted
| Metric | NUVB | NRIX |
|---|---|---|
| Price | $4.67 | $15.92 |
| Market cap | $1.64B | $1.74B |
| Today | −0.53% | −38.34% |
| 1 month | −4.4% | −29.6% |
| 6 months | −7.4% | −5.7% |
| Year to date | −47.9% | −16.1% |
| 1 year | −9.8% | +26.1% |
| Revenue growth (YoY) | +555.6% | +8426.3% |
| Gross margin | 73.0% | 100.0% |
| Net margin | −198.3% | 81.7% |
| P/E (TTM) | — | 5.9× |
| Price / sales | 9.6× | 2.5× |
| Net cash | $399.4M | $1.05B |
| Dividend yield | — | — |
| Volatility (60d) | 50.7% | 105.0% |
| Short % of float | 23.9% | 21.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).